Clinical Trial Update: SGLT2i Therapy in Islet Transplantation (SIT) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating SGLT2 inhibitors as adjunct therapy in islet transplantation for people with partial islet function or undergoing total p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: University of Minnesota | Conditions: Partial Islet Function, TPIAT | Phase 4 | Status: NOT_YET_RECRUITING